Analysis of microglial gene expression: Identifying targets for CNS neurodegenerative and autoimmune disease

American Journal of PharmacoGenomics

Volumn 4, Issue 5, 2004, Pages 321-330

  Carson, Monica J ^a,c   Thrash, J Cameron ^a   Lo, David ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Digital Gene Technologies Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD45 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 12; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; AUTOIMMUNE DISEASE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SERIAL ANALYSIS OF GENE EXPRESSION; TOTAL GENE ANALYSIS;

ANIMALIA; EUKARYOTA;

EID: 7544246271     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200404050-00005     Document Type: Review

References (64)

1. Lo D, Feng LL, Li L, et al. Integrating innate and adaptive immunity in the whole animal. Immunol Rev 1999; 169: 225-39
2. Carson MJ. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 2002; 40 (2): 218-31
3. Streit WJ. Microglial response to brain injury: a brief synopsis. Toxicol Pathol 2000; 28 (1): 28-30
4. Aloisi F. Immune function of microglia. Glia 2001; 36 (2): 165-79
5. Matyszak MK. Inflammation in the CNS: balance between immunological privilege and immune responses. Prog Neurobiol 1998; 56 (1): 19-35
6. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19(8): 312-8
7. Balcaitis S, Xie Y, Weinstein JR, et al. Expression of proteinase-activated receptors in mouse microglial cells. Neuroreport 2003; 14 (18): 2373-7
8. Moller T, Hanisch UK, Ransom BR. Thrombin-induced activation of cultured rodent microglia. J Neurochem 2000; 75 (4): 1539-47
9. Boucsein C, Zacharias R, Farber K, et al. Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 2003; 17 (11): 2267-76
10. Mickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239 (4837): 290-2
11. Matsumoto Y, Fujiwara M. Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J Neuroimmunol 1987; 17(1): 71-82
12. Vallieres L, Sawchenko PE. Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003; 23 (12): 5197-207
13. Sedgwick JD, Schwender S, Imrich H, et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A 1991; 88 (16): 7438-42
14. Renno T, Krakowski M, Piccirillo C, et al. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: regulation by Th1 cytokines. J Immunol 1995; 154 (2): 944-53
15. Carson MJ, Reilly CR, Sutcliffe JG, et al. Mature microglia resemble immature antigen-presenting cells. Glia 1998; 22 (1): 72-85
16. Irie-Sasaki J, Sasaki T, Penninger JM. CD45 regulated signaling pathways. Curr Top Med Chem 2003; 3 (7): 783-96
17. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003; 21: 107-37
18. Penninger JM, Irie-Sasaki J, Sasaki T, et al. CD45: new jobs for an old acquaintance. Nat Immunol 2001; 2 (5): 389-96
19. Tan J, Town T, Mon T, et al. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. J Neurosci 2000; 20 (20): 7587-94
20. Tan J, Town T, Mullan M. CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 2000; 275 (47): 37224-31
21. Hailer NP, Heppner FL, Haas D, et al. Fluorescent dye prelabelled microglial cells migrate into organotypic hippocampal slice cultures and ramify. Eur J Neurosci 1997; 9(4): 863-6
22. Carson MJ, Reilly CR, Sutcliffe JG, et al. Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol 1999; 154 (2): 481-94
23. Ploix C, Lo D, Carson MJ. A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol 2001; 167 (12); 6724-30
24. Popovich PG, Hickey WF. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J Neuropathol Exp Neurol 2001; 60 (7): 676-85
25. Popovich PG, van Rooijen N, Hickey WF, et al. Hematogenous macrophages express CD8 and distribute to regions of lesion cavitation after spinal cord injury. Exp Neurol 2003; 182 (2): 275-87
26. Byram SC, Carson MJ, Deboy CA, et al. CD4+T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 2004; 24 (18): 4333-9
27. Raivich G, Jones LL, Kloss CU, et al. Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 1998; 18 (15): 5804-16
28. Serpe CJ, Kohm AP, Huppenbauer CB, et al. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci 1999; 19(11): RC7
29. Medzhitov R, Janeway Jr CA. Innate immune recognition and control of adaptive immune responses. Semin Immunol 1998; 10 (5): 351-3
30. Bauer J, Huitinga I, Zhao W, et al. The role of macrophages, perivascular cells, and microglial cells in the pathogenesis of experimental autoimmune encephalomyelitis. Glia 1995; 15 (4): 437-46
31. Becher B, Durell BG, Noelle RJ. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J Clin Invest 2003; 112 (8): 1186-91
32. Becher B, Durell BG, Miga AV, et al. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 2001; 193 (8): 967-74
33. Yamamoto M, Wakatsuki T, Hada A, et al. Use of serial analysis of gene expression (SAGE) technology. J Immunol Methods 2001; 250 (1-2): 45-66
34. Sutcliffe JG, Foye PE, Erlander MG, et al. TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci U S A 2000; 97(5): 1976-81
35. Moran LB, Duke DC, Turkheimer FE, et al. Towards a transcriptome definition of microglial cells. Neurogenetics 2004; 5 (2): 95-108
36. Inoue H, Sawada M, Ryo A, et al. Serial analysis of gene expression in a microglial cell line. Glia 1999; 28 (3): 265-71
37. Sutcliffe JG. Open-system approaches to gene expression in the CNS. J Neurosci 2001; 21 (21): 8306-9
38. Schmid CD, Sautkulis LN, Danielson PE, et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem 2002; 83 (6): 1309-20
39. Pedersen EB, McNulty JA, Castro AJ, et al. Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats. J Neuroimmunol 1997; 76(1-2): 117-31
40. McCluskey LP, Lampson LA. Local immune regulation in the central nervous system by substance P vs glutamate. J Neuroimmunol 2001; 116 (2): 136-46
41. Flaris NA, Densmore TL, Molleston MC, et al. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 1993; 7 (1): 34-40
42. Bouchon A, Hernandez-Munain C, Cella M, et al. A dap12-mediated pathway regulates expression of cc chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001; 194 (8): 1111-22
43. Daws MR, Sullam PM, Niemi EC, et al. Pattern recognition by TREM-2: binding of anionic ligands. J Immunol 2003; 171 (2): 594-9
44. Paloneva J, Autti T, Raininko R, et al. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology 2001; 56 (11): 1552-8
45. Brower V. Harnessing the immune system to battle Alzheimer's: some of the most promising approaches to fight Alzheimer's disease aim to develop vaccines. EMBO Rep 2002; 3 (3): 207-9
46. Senior K. Dosing in phase II trial of Alzheimer's vaccine suspended. Lancet Neurol 2002; 1 (1): 3
47. Birmingham K, Frantz S. Set back to Alzheimer vaccine studies. Nat Med 2002; 8 (3): 199-200
48. Baker CA, Manuelidis L. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 2003; 100 (2): 675-9
49. Baker CA, Martin D, Manuelidis L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol 2002; 76(21): 10905-13
50. Thomas EA, Laws SM, Sutcliffe JG, et al. Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol Psychiatry 2003; 54 (2): 136-41
51. Thomas EA, George RC, Sutcliffe JG. Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot Essent Fatty Acids 2003; 69 (6): 421-7
52. Teunissen CE, Dijkstra CD, Polman CH, et al. Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci Lett 2003; 347 (3): 159-62
53. Diestel A, Aktas O, Hackel D, et al. Activation of microglial poly (ADP-ribose)-polymerase 1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J Exp Med 2003; 198 (11): 1729-40
54. Morra VB, Coppola G, Orefice G, et al. Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. Neurology 2004; 62 (5): 829-30
55. Stuve O, Prod'homme T, Youssef S, et al. Stalins as potential therapeutic agents in multiple sclerosis. Curr Neurol Neurosci Rep 2004; 4 (3): 237-44
56. Neumann H. Control of glial immune function by neurons. Glia 2001; 36 (2): 191-9
57. Neumann H, Misgeld T, Matsumuro K, et al. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci U S A 1998; 95 (10): 5779-84
58. Delgado R, Carlin A, Airaghi L, et al. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J Leukoc Biol 1998; 63 (6): 740-5
59. Kim WK, Kan Y, Ganea D, et al. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway. J Neurosci 2000; 20 (10): 3622-30
60. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290 (5497): 1768-71
61. Mott RT, Ait-Ghezala G, Town T, et al. Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 2004; 46 (4): 369-79
62. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003; 69 (5): 313-40
63. Carson MJ, Sutcliffe JG, Campbell IL. Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res 1999; 55 (1): 127-34
64. Becher B, Antel JP. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 1996; 18 (1): 1-10